Clinical Trials on Non-alcoholic Fatty Liver Disease in New Zealand

Total 4526 results

Malaghan Institute of Medical Research
Wellington Zhaotai Therapies Limited (WZTL)

Recruiting

ENABLE (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) (ENABLE)

Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Lymphomas Non-Hodgkin's B-Cell | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL)

New Zealand
National Medical Research Council (NMRC), Singapore

Completed

Tamoxifen in Treating Patients With Primary Liver Cancer

Liver Cancer

New Zealand, Hong Kong, Indonesia, Malaysia, Pakistan, Singapore
Hoffmann-La Roche

Completed

A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1

Hepatitis C, Chronic, Healthy Volunteer

New Zealand
Novartis Pharmaceuticals

Terminated

A Two Week Dosing Study to Determine the Safety and Antiviral Activity of LCQ908 in Hepatitis C Patients

Hepatitis C

New Zealand
Assembly Biosciences

Completed

A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects

Chronic Hepatitis B

New Zealand
Arbutus Biopharma Corporation

Recruiting

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Chronic Hepatitis b

New Zealand
Gilead Sciences

Completed

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection (LEPTON)

Chronic Hepatitis C

New Zealand
New York State Psychiatric Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV

Binge Drinking | Hepatitis C | HIV/AIDS | Alcohol Use Disorder

United States
Qilu Pharmaceutical Co., Ltd.

Unknown

A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Hepatitis B Patients

Chronic Hepatitis b

New Zealand
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Chronic Hepatitis C

New Zealand
Partnership to End Addiction
Feinstein Institute for Medical Research

Active, not recruiting

Messaging Interventions to Reduce Alcohol Problems Project (MIRAP)

Alcohol Drinking | Alcoholism | Alcohol-Related Disorders | Alcohol Use Disorders | Alcohol Abuse

United States
New York State Psychiatric Institute

Completed

Pregabalin as Treatment for Alcohol Use Disorder

Alcohol Use Disorder

United States
Rockefeller University
Cornell University

Completed

Relation of Obesity With Frequency of Meals (MST 0557)

Obesity | Fatty Liver | Insulin Resistance

United States
Gilead Sciences

Completed

Efficacy and Safety of Tenofovir Alafenamide (TAF) Versus Tenofovir Disoproxil Fumarate (TDF)-Containing Regimens in Participants With Chronic Hepatitis B Virus (HBV) Infection and Stage 2 or Greater Chronic Kidney Disease Who Have Received a Liver Transplant

Chronic Hepatitis B

New Zealand
Arrowhead Pharmaceuticals

Completed

Study of ARO-AAT in Normal Adult Volunteers

Alpha 1-Antitrypsin Deficiency

New Zealand
Enanta Pharmaceuticals, Inc

Terminated

A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.

Chronic Hepatitis B Virus Infection

New Zealand
Antipodean Pharmaceuticals, Inc.

Completed

Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C

Chronic Hepatitis C

New Zealand
Northwell Health

Withdrawn

Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal

Alcohol Use Disorder | Alcohol Withdrawal

United States
Yale University

Terminated

Promoting Medications for Alcohol Use Disorder on the General Medicine Service

Alcohol Use Disorder

United States
Arrowhead Pharmaceuticals

Terminated

A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)

Hepatitis B

New Zealand
NYU Langone Health
National Institutes of Health (NIH); Tilray

Completed

Effects of Cannabidiol in Alcohol Use Disorder

Alcohol Use Disorder

United States
Vertex Pharmaceuticals Incorporated

Completed

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-135 and Daclatasvir in Subjects With Genotype 1 Chronic Hepatitis C Chronic Hepatitis C

Hepatitis C | Chronic Hepatitis C | HCV | CHC

New Zealand
Northwell Health

Completed

Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic Ultrasound

Alcoholism | Cirrhosis | Hepatitis c

United States
Northwell Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Adaptive Interventions for Problem Drinkers

Alcohol Drinking | Alcoholism | Alcohol-Related Disorders | Alcohol Use Disorders | Alcohol Abuse

United States
Northwell Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Component Analysis for Motivational Interviewing

Alcohol Drinking | Alcoholism | Alcohol-Related Disorders | Alcohol Use Disorders | Alcohol Abuse

United States
Assembly Biosciences

Completed

A Study in Healthy Volunteers and Patients With Chronic Hepatitis B

Chronic Hepatitis B

New Zealand
Virion Therapeutics

Recruiting

Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy

Chronic Hepatitis B

Hong Kong, New Zealand
Alios Biopharma Inc.

Terminated

Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Disoproxil Fumarate in Healthy Volunteers

Hepatitis B | Chronic Hepatitis B | Viral Hepatitis B

New Zealand
Northwell Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Tailored Mobile Text Messaging to Reduce Problem Drinking

Alcohol Drinking | Alcoholism | Alcohol-Related Disorders | Alcohol Use Disorders | Alcohol Abuse

United States
Gilead Sciences

Completed

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

Chronic Hepatitis C Infection

New Zealand
State University of New York - Upstate Medical...

Completed

Improving Hepatitis C Treatment in Injection Drug Users

Liver Diseases | Alcoholism | Hepatitis C | Drug Abuse

United States
NYU Langone Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

Alcohol Dependence | Alcohol Use Disorder

United States
Novira Therapeutics, Inc.

Completed

Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients

Chronic Hepatitis B

New Zealand
Research Foundation for Mental Hygiene, Inc.

Completed

Reducing Unsafe Alcohol Use in HIV-Positive Individuals

Alcohol Abuse

United States
AbbVie

Completed

Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function

Hepatic Impairment

United States, New Zealand
Arbor Research Collaborative for Health
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...

Recruiting

Longitudinal Study of Mitochondrial Hepatopathies (MITOHEP)

End Stage Liver Disease | Mitochondrial Diseases | Acute Liver Failure | Respiratory Chain Deficiencies, Mitochondrial | Disorder of Fatty Acid Oxidation

United States, Canada
Govind Ballabh Pant Hospital

Unknown

Granulocyte Colony Stimulating Factor(G-CSF) Therapy for Patients With ACLF

Acute on Chronic Liver Failure

India
Research Foundation for Mental Hygiene, Inc.
Montefiore Medical Center

Terminated

Targeting Non-virally Suppressed Adults With Alcohol Use Disorder in HIV Primary Care

Alcohol Dependence | HIV/AIDS

United States
Yale University

Completed

Chronic Alcohol, Stress Inflammatory Response and Relapse Risk

Alcohol Dependence | Depressive Symptomatology

United States
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Prognostic Significance of Acute Change in Liver and Splenic Stiffness in Patients of Acute on Chronic Liver Failure

Acute on Chronic Liver Failure

India
Aligos Therapeutics

Terminated

A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects

Chronic Hepatitis B

United Kingdom, New Zealand
National Institute on Alcohol Abuse and Alcoholism...
Arbor Pharmaceuticals, Inc.

Completed

HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder

Alcohol Use Disorder

United States
Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Yale University; VA... and other collaborators

Completed

Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action (Z-Comp)

Alcohol Use Disorder

United States
Stony Brook University

Recruiting

Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD)

Alcohol Abstinence

United States
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Completed

Study of DCR-A1AT in Healthy Adult Volunteers

Alpha 1-Antitrypsin Deficiency

New Zealand, Sweden
Yale University
National Institutes of Health (NIH)

Completed

Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD

Fatty Liver | Insulin Resistance

United States
Institute of Liver and Biliary Sciences, India

Recruiting

Acute Hemodynamic Response to Carvedilol in Predicting Survival in Acute on Chronic Liver Failure Patients - A Pilot Study.

Acute on Chronic Liver Failure

India
Institute of Liver and Biliary Sciences, India

Unknown

Efficacy of Albumin Plus Midodrine v/s Albumin Alone in Reducing Incidence of Paracentesis Induced Circulatory Dysfunctions in ACLF Patients.

Acute-On-Chronic Liver Failure

India
Institute of Liver and Biliary Sciences, India

Completed

Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction In Acute-On-Chronic Liver Failure.

Acute on Chronic Liver Failure

India
Institute of Liver and Biliary Sciences, India

Completed

High Volume Plasma Exchange in Children With Acute Liver Failure and Acute on Chronic Liver Failure

Acute Liver Failure

India

Clinical Trials on Non-alcoholic Fatty Liver Disease in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations